Cargando…

iNOS is associated with tumorigenicity as an independent prognosticator in human intrahepatic cholangiocarcinoma

BACKGROUND: Inducible nitric oxide synthase (iNOS) has supposed to implicate in inflammation, infection, liver cirrhosis, and neoplastic diseases. This study was designed to explore the biological and clinical function of iNOS in intrahepatic cholangiocarcinoma (ICC). METHODS: RT-PCR (Real-time quan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Sulai, Jiang, Jinqiong, Huang, Linsheng, Jiang, Yu, Yu, Nanhui, Liu, Xiehong, Lv, Yuan, Li, Hao, Zou, Lianhong, Peng, Chuang, Yu, Xing, Jiang, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716572/ https://www.ncbi.nlm.nih.gov/pubmed/31692584 http://dx.doi.org/10.2147/CMAR.S208773

Ejemplares similares

iNOS is Associated with Tumorigenicity as an Independent Prognosticator in Human Intrahepatic Cholangiocarcinoma [Retraction]
Publicado: (2023)

Wip1 is associated with tumorigenity and metastasis through MMP-2 in human intrahepatic cholangiocarcinoma
por: Liu, Sulai, et al.
Publicado: (2017)

Tangeretin inhibits hepatocellular carcinoma proliferation and migration by promoting autophagy-related BECLIN1
por: Zheng, Jiao, et al.
Publicado: (2019)

Ganoderma lucidum Triterpenoids (GLTs) Reduce Neuronal Apoptosis via Inhibition of ROCK Signal Pathway in APP/PS1 Transgenic Alzheimer's Disease Mice
por: Yu, Nanhui, et al.
Publicado: (2020)

Curcumol inhibits the proliferation and metastasis of melanoma via the miR-152-3p/PI3K/AKT and ERK/NF-κB signaling pathways
por: Ning, Ning, et al.
Publicado: (2020)

PPM1D is a potential prognostic biomarker and correlates with immune cell infiltration in hepatocellular carcinoma
por: Yu, Zhangtao, et al.
Publicado: (2021)

MicroRNA-129-2-3p directly targets Wip1 to suppress the proliferation and invasion of intrahepatic cholangiocarcinoma
por: Chen, Chen, et al.
Publicado: (2020)

Insights into the role of STAT3 in intrahepatic cholangiocarcinoma
por: Yang, Ranzhiqiang, et al.
Publicado: (2022)

The focus clinical research in intrahepatic cholangiocarcinoma
por: Song, Yinghui, et al.
Publicado: (2022)

Correction to: The focus clinical research in intrahepatic cholangiocarcinoma
por: Song, Yinghui, et al.
Publicado: (2022)

Clinicopathological findings and imaging features of intraductal papillary neoplasms in bile ducts
por: Zhang, Honghui, et al.
Publicado: (2020)

Intrahepatic Cholangiocarcinoma: State of the Art of FGFR Inhibitors
por: Wu, Tianyu, et al.
Publicado: (2021)

Obesity-Induced Coronary Microvascular Disease Is Prevented by iNOS Deletion and Reversed by iNOS Inhibition
por: Shah, Soham A., et al.
Publicado: (2023)

The dual role of iNOS in cancer()
por: Vannini, Federica, et al.
Publicado: (2015)

CUL4A overexpression as an independent adverse prognosticator in intrahepatic cholangiocarcinoma
por: Huang, Gong -Kai, et al.
Publicado: (2017)

iNOS expression and osteocyte apoptosis in idiopathic, non-traumatic osteonecrosis
por: Wang, Jun, et al.
Publicado: (2015)

Brain function in iNOS knock out or iNOS inhibited (l-NIL) mice under endotoxic shock
por: Schweighöfer, Hanna, et al.
Publicado: (2014)

Nanoparticle encapsulated CQ/TAM combination harmonizes with MSCs in arresting progression of severity in AP mice through iNOS (IDO) signaling
por: Liu, Huimin, et al.
Publicado: (2022)

The genetic association between iNOS and eNOS polymorphisms and gastric cancer risk: a meta-analysis
por: Zhu, Yi, et al.
Publicado: (2018)

Intrahepatic Cholestasis of Pregnancy Is Associated with Reduced Nitric Oxide Synthase (iNOS) in Plasma and Placentas: A Pilot Study
por: Wang, Yun, et al.
Publicado: (2021)

Sarcomatoid Intrahepatic Cholangiocarcinoma After Immunotherapy: A Case Report and Review of the Literature
por: Zeng, Zheng, et al.
Publicado: (2022)

The expressions of AMACR and iNOS in prostate adenocarcinomas
por: Ozgur, Tumay, et al.
Publicado: (2013)

Targeting iNOS to increase efficacy of immunotherapies
por: Ekmekcioglu, Suhendan, et al.
Publicado: (2017)

A Combination of 3D-QSAR, Molecular Docking and Molecular Dynamics Simulation Studies of Benzimidazole-Quinolinone Derivatives as iNOS Inhibitors
por: Zhang, Hao, et al.
Publicado: (2012)

iNOS dependent and independent phases of lymph node expansion in mice with TNF-induced inflammatory-erosive arthritis
por: Bell, Richard D., et al.
Publicado: (2019)

Upregulation of iNOS and phosphorylated eNOS in the implantation‐induced blastocysts of mice
por: Seki, Misato, et al.
Publicado: (2023)

iNOS polymorphism modulates iNOS/NO expression via impaired antioxidant and ROS content in P. vivax and P. falciparum infection
por: Kumar, Amod, et al.
Publicado: (2017)

Hepatic Lysosomal iNOS Activity Impairs Autophagy in Obesity
por: Qian, Qingwen, et al.
Publicado: (2019)

A case report of rectal adenocarcinoma with intrahepatic cholangiocarcinoma of the liver
por: Guo, Jing-qiang, et al.
Publicado: (2019)

Aging and Insulin Resistance: Just Say iNOS
por: Evans, Joseph L., et al.
Publicado: (2013)

The influence of resection margin width in patients with intrahepatic cholangiocarcinoma: a meta-analysis
por: Dai, Yu-Shi, et al.
Publicado: (2023)

Liver transplantation for intrahepatic cholangiocarcinoma: a propensity score-matched analysis
por: Huang, Gaobo, et al.
Publicado: (2023)

Integrin β3 and LKB1 are independently involved in the inhibition of proliferation by lovastatin in human intrahepatic cholangiocarcinoma
por: Yang, Sheng-Huei, et al.
Publicado: (2015)

Recipient iNOS but Not eNOS Deficiency Reduces Luminal Narrowing in Tracheal Allografts
por: Minamoto, Kanji, et al.
Publicado: (2002)

Sildenafil Ameliorates Gentamicin-Induced Nephrotoxicity in Rats: Role of iNOS and eNOS
por: Morsy, Mohamed A., et al.
Publicado: (2014)

Clinical Implications of iNOS Levels in Triple-Negative Breast Cancer Responding to Neoadjuvant Chemotherapy
por: Jin, Zining, et al.
Publicado: (2015)

The return of the Scarlet Pimpernel: cobalamin in inflammation II — cobalamins can both selectively promote all three nitric oxide synthases (NOS), particularly iNOS and eNOS, and, as needed, selectively inhibit iNOS and nNOS
por: Wheatley, Carmen
Publicado: (2007)

Intrahepatic Sarcomatoid Cholangiocarcinoma
por: Malhotra, Shalini, et al.
Publicado: (2010)

Asbestos and Intrahepatic Cholangiocarcinoma
por: Brandi, Giovanni, et al.
Publicado: (2020)

Management of Intrahepatic Cholangiocarcinoma
por: Kodali, Sudha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8mokhuud3ui9c3n4aud4cfspfb